{"id":"AIBD-1234","title":"Diario de Mallorca reports that QP Prostate marked a tiny lesion on a 58-year-old man's MRI at Clínica Girona, a biopsy confirmed cancer, and after surgery he says he is free of disease","summary":"Diario de Mallorca reports that QP Prostate marked a tiny lesion on a 58-year-old man's MRI at Clínica Girona. A biopsy confirmed cancer, and after surgery he says he is free of disease.","date_observed":"2026-11-05","date_basis":"source publication","date_precision":"day","benefit_status":"reported","account":"Quibim, a company in Valencia, makes QP Prostate, an AI assistant that marks likely prostate cancer lesions on MRI. Diario de Mallorca reported on 5 November 2026 that the tool is in use at 12 public hospitals and eight private centers in Spain. At Clínica Girona, it marked a tiny lesion in red on a 58-year-old man's prostate MRI. The radiologist advised a biopsy, which confirmed cancer. The man was operated on nine months before the report. He says that he is now free of disease and credits the AI with finding the tumor when it was tiny. The account is the patient's and the clinic's, and no source says whether radiologists would have found the lesion without the tool.","category":"harm prevented","unexpected":false,"purpose":"Quibim built QP Prostate to mark and grade likely prostate cancer lesions on MRI for radiologists.","system":"QP Prostate","model_version":null,"developer":"Quibim","deployer":"Clínica Girona (radiology department)","location":"Girona, Spain","domain":"Healthcare (radiology)","segment":null,"registry_ids":{},"ratings":[{"group":"personal","depth":4,"reason":"A tiny prostate cancer was found, confirmed and removed, and the man reports that he is free of disease."}],"ai_role":{"status":"unassessed","statement":"The tool marked the lesion and the radiologist advised the biopsy. No source compares the reading with and without the tool."},"evidence":[{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"Gracias a la IA, me detectaron el tumor cuando era ínfimo, me operaron y ahora estoy libre de enfermedad.","quote_translation":"Thanks to the AI, they detected the tumor when it was tiny, I was operated on and now I am free of disease."},{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026. On the reading and the biopsy.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"el 'asistente inteligente' \"se la marcó en rojo\". Por eso, aconsejó realizarle una biopsia, que confirmó el diagnóstico definitivo de cáncer.","quote_translation":"the 'intelligent assistant' \"marked it in red.\" He therefore advised a biopsy, which confirmed the definitive diagnosis of cancer."},{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026. On the tool's use in Spain.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"Se trata de QP Prostate, un 'asistente inteligente' que, por el momento, está implantado en 12 hospitales públicos y ocho centros privados españoles","quote_translation":"It is QP Prostate, an 'intelligent assistant' that is currently deployed in 12 public hospitals and eight private centers in Spain.","supports_benefit":false}],"replication":{"produced_by":["An AI assistant that marks and grades likely lesions on prostate MRI","A radiologist who reviews the marks and advises a biopsy"],"must_hold":["A radiologist must review each mark","A biopsy must confirm the finding before treatment"],"echoes":[]},"paired_incident":null,"headline":"*QP Prostate* flags a tiny tumor that a biopsy confirms in Girona","metric":null,"comparator":null,"later":{"status":"unknown","date":null,"note":"The benefit was first reported on 5 November 2026, and no later report was found.","quote":null,"url":null},"learns_from_data":{"value":"not shown","note":"The report does not describe how the tool was built.","quote":null,"url":null},"benefit_categories":["physical_health"],"scsp_example":"Medical diagnosis","size":{"reach":{"band":1,"fact":"One man had his cancer found and treated.","quote":"Gracias a la IA, me detectaron el tumor cuando era ínfimo, me operaron y ahora estoy libre de enfermedad.","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","reason":null},"duration":{"band":null,"fact":null,"quote":null,"url":null,"reason":"The man reports that he is free of disease nine months after surgery, too soon to show a lasting cure."},"distribution":{"band":null,"fact":null,"quote":null,"url":null,"reason":"The benefit went to one man, and no groups are compared."},"frequency":{"band":1,"fact":"One lesion was found, once.","quote":"el 'asistente inteligente' \"se la marcó en rojo\". Por eso, aconsejó realizarle una biopsia, que confirmó el diagnóstico definitivo de cáncer.","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","reason":null}},"value":null,"developer_country":"Spain","deployer_country":"Spain","unrated_because":null,"brief_notes":null,"brief":null,"confidence":"reported","shade":"medium","claim_status":"Independently reported","claim_basis":"Sources: one independent news report. For the benefit itself, the cited sources include no independent study or research report and no finding by an external body.","case_jurisdictions":["Spain"],"design":"no comparison","certainty":"very low","certainty_reasons":["Starts very low because no comparison was measured."],"profile":{"case_id":"AIBD-1234","source_ids":["AIBD-1234-source-0001","AIBD-1234-source-0002","AIBD-1234-source-0003"],"families":{"strategic assessments":{"state":"unresolved","record_ids":[]},"evaluations":{"state":"unresolved","record_ids":[]},"monetary observations":{"state":"unresolved","record_ids":[]},"institutional decisions":{"state":"unresolved","record_ids":[]}},"fields":{"actors[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"developer":"Quibim","deployer":"Clínica Girona (radiology department)"}}},"actors[].ownership_control":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"ai_contribution":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"ai_relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"category":"harm prevented","ai_role":{"status":"unassessed","statement":"The tool marked the lesion and the radiologist advised the biopsy. No source compares the reading with and without the tool."}}}},"assessments[].alternatives":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"assessments[].assessor_date":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"assessments[].depth":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"personal","depth":4,"reason":"A tiny prostate cancer was found, confirmed and removed, and the man reports that he is free of disease."}]}}},"assessments[].display_confidence":{"state":"value_present","value":{"kind":"structured","data":{"confidence":"medium","evidence_word":"reported","claim_status":"Independently reported","basis":"Sources: one independent news report. For the benefit itself, the cited sources include no independent study or research report and no finding by an external body.","interpretation":"Existing display rule preserved; the richer outcome-specific confidence question still needs review."}}},"assessments[].rationale":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"personal","depth":4,"reason":"A tiny prostate cancer was found, confirmed and removed, and the man reports that he is free of disease."}]}}},"assessments[].rubric_version":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"assessments[].status_basis":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"assessments[].target":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"personal","depth":4,"reason":"A tiny prostate cancer was found, confirmed and removed, and the man reports that he is free of disease."}]}}},"availability":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"brief":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"case_kind":{"state":"value_present","value":{"kind":"structured","data":{"classification":"individual experience","answer":"An individual experience. One patient's diagnosis.","scope":"The period and activity described in the case."}},"display":{"answer":"An individual experience. One patient's diagnosis.","inferred":false},"source_refs":["AIBD-1234-source-0001"]},"case_links[]":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"claims[].evidence_links":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"claims[].evidence_strength":{"state":"value_present","value":{"kind":"structured","data":{"answer":"Independently reported. Sources: one independent news report. For the benefit itself, the cited sources include no independent study or research report and no finding by an external body.","evidence_word":"reported","claim_status":"Independently reported"}},"display":{"answer":"Independently reported. Sources: one independent news report. For the benefit itself, the cited sources include no independent study or research report and no finding by an external body.","inferred":false},"source_refs":["AIBD-1234-source-0001","AIBD-1234-source-0002","AIBD-1234-source-0003"]},"claims[].missingness":{"state":"value_present","value":{"kind":"text","text":"The account is one patient's and his clinic's. No source compares the reading with and without the tool."},"display":{"answer":"The account is one patient's and his clinic's. No source compares the reading with and without the tool.","inferred":false},"source_refs":["AIBD-1234-source-0001"]},"claims[].proposition":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"cross_border_flows[]":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"decisions[].action_outcome":{"state":"unresolved","family":"institutional decisions"},"decisions[].grounds":{"state":"unresolved","family":"institutional decisions"},"decisions[].institution_task":{"state":"unresolved","family":"institutional decisions"},"decisions[].success_criterion":{"state":"unresolved","family":"institutional decisions"},"deployment_stage":{"state":"value_present","value":{"kind":"structured","data":{"classification":"routine use","answer":"The system was in routine use. The tool is in use at 20 Spanish hospitals and centers.","scope":"The period and activity described in the case."}},"display":{"answer":"The system was in routine use. The tool is in use at 20 Spanish hospitals and centers.","inferred":false},"source_refs":["AIBD-1234-source-0001"]},"economics[].amount":{"state":"unresolved","family":"monetary observations"},"economics[].costs[]":{"state":"unresolved","family":"monetary observations"},"economics[].counterfactual":{"state":"unresolved","family":"monetary observations"},"economics[].currency_price_basis":{"state":"unresolved","family":"monetary observations"},"economics[].gross_net":{"state":"unresolved","family":"monetary observations"},"economics[].measure_type":{"state":"unresolved","family":"monetary observations"},"economics[].period_unit":{"state":"unresolved","family":"monetary observations"},"economics[].realization":{"state":"unresolved","family":"monetary observations"},"economics[].recipient_payer":{"state":"unresolved","family":"monetary observations"},"economics[].return_payback":{"state":"unresolved","family":"monetary observations"},"economics[].valuation_method":{"state":"unresolved","family":"monetary observations"},"evaluations[].ai_uplift":{"state":"unresolved","family":"evaluations"},"evaluations[].comparator":{"state":"unresolved","family":"evaluations"},"evaluations[].design":{"state":"unresolved","family":"evaluations"},"evaluations[].effect":{"state":"unresolved","family":"evaluations"},"evaluations[].exposure":{"state":"unresolved","family":"evaluations"},"evaluations[].id":{"state":"unresolved","family":"evaluations"},"evaluations[].measurement_method":{"state":"unresolved","family":"evaluations"},"evaluations[].metric":{"state":"unresolved","family":"evaluations"},"evaluations[].reproduction_materials":{"state":"unresolved","family":"evaluations"},"evaluations[].setting_sample":{"state":"unresolved","family":"evaluations"},"evaluations[].uncertainty_limitations":{"state":"unresolved","family":"evaluations"},"external_references[]":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"follow_up[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"later":{"status":"unknown","note":"The benefit was first reported on 5 November 2026, and no later report was found."}}}},"human_oversight":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"id":{"state":"value_present","value":{"kind":"record_fields","fields":{"id":"AIBD-1234"}}},"infrastructure_dependencies[]":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"outcomes[].beneficiaries":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"outcomes[].beneficiary_count":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"outcomes[].claim":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"Quibim, a company in Valencia, makes QP Prostate, an AI assistant that marks likely prostate cancer lesions on MRI. Diario de Mallorca reported on 5 November 2026 that the tool is in use at 12 public hospitals and eight private centers in Spain. At Clínica Girona, it marked a tiny lesion in red on a 58-year-old man's prostate MRI. The radiologist advised a biopsy, which confirmed cancer. The man was operated on nine months before the report. He says that he is now free of disease and credits the AI with finding the tumor when it was tiny. The account is the patient's and the clinic's, and no source says whether radiologists would have found the lesion without the tool."}}},"outcomes[].distribution":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"outcomes[].duration":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"outcomes[].id":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"outcomes[].stakeholder_group":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"personal","depth":4,"reason":"A tiny prostate cancer was found, confirmed and removed, and the man reports that he is free of disease."}]}}},"outcomes[].status":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_status":"reported"}}},"outcomes[].tradeoffs":{"state":"value_present","value":{"kind":"text","text":"No costs or harms are reported in the sources."},"display":{"answer":"No costs or harms are reported in the sources.","inferred":false},"source_refs":["AIBD-1234-source-0001","AIBD-1234-source-0002","AIBD-1234-source-0003"]},"outcomes[].unexpected":{"state":"value_present","value":{"kind":"record_fields","fields":{"unexpected":false,"purpose":"Quibim built QP Prostate to mark and grade likely prostate cancer lesions on MRI for radiologists."}}},"places[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"location":"Girona, Spain","developer_country":"Spain","deployer_country":"Spain"}}},"purpose":{"state":"value_present","value":{"kind":"record_fields","fields":{"purpose":"Quibim built QP Prostate to mark and grade likely prostate cancer lesions on MRI for radiologists."}}},"record_dates":{"state":"value_present","value":{"kind":"record_fields","fields":{"date_observed":"2026-11-05","date_basis":"source publication","date_precision":"day"}}},"replication.attempts[]":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"replication.conditions":{"state":"value_present","value":{"kind":"record_fields","fields":{"replication":{"produced_by":["An AI assistant that marks and grades likely lesions on prostate MRI","A radiologist who reviews the marks and advises a biopsy"],"must_hold":["A radiologist must review each mark","A biopsy must confirm the finding before treatment"],"echoes":[]}}}},"sector":{"state":"value_present","value":{"kind":"record_fields","fields":{"domain":"Healthcare (radiology)"}}},"sources[].access_version":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"sources[].citation_locator":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"Gracias a la IA, me detectaron el tumor cuando era ínfimo, me operaron y ahora estoy libre de enfermedad.","quote_translation":"Thanks to the AI, they detected the tumor when it was tiny, I was operated on and now I am free of disease."},{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026. On the reading and the biopsy.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"el 'asistente inteligente' \"se la marcó en rojo\". Por eso, aconsejó realizarle una biopsia, que confirmó el diagnóstico definitivo de cáncer.","quote_translation":"the 'intelligent assistant' \"marked it in red.\" He therefore advised a biopsy, which confirmed the definitive diagnosis of cancer."},{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026. On the tool's use in Spain.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"Se trata de QP Prostate, un 'asistente inteligente' que, por el momento, está implantado en 12 hospitales públicos y ocho centros privados españoles","quote_translation":"It is QP Prostate, an 'intelligent assistant' that is currently deployed in 12 public hospitals and eight private centers in Spain.","supports_benefit":false}]}}},"sources[].id":{"state":"value_present","value":{"kind":"identifiers","identifiers":["AIBD-1234-source-0001","AIBD-1234-source-0002","AIBD-1234-source-0003"],"role":"Existing evidence items, in their original order"}},"sources[].language":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"sources[].relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"Gracias a la IA, me detectaron el tumor cuando era ínfimo, me operaron y ahora estoy libre de enfermedad.","quote_translation":"Thanks to the AI, they detected the tumor when it was tiny, I was operated on and now I am free of disease."},{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026. On the reading and the biopsy.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"el 'asistente inteligente' \"se la marcó en rojo\". Por eso, aconsejó realizarle una biopsia, que confirmó el diagnóstico definitivo de cáncer.","quote_translation":"the 'intelligent assistant' \"marked it in red.\" He therefore advised a biopsy, which confirmed the definitive diagnosis of cancer."},{"kind":"news report","citation":"Diario de Mallorca, 5 November 2026. On the tool's use in Spain.","title":"Cáncer de próstata, IA y resonancia: diagnóstico","url":"https://www.diariodemallorca.es/sociedad/2026/11/05/cancer-prostata-ia-resonancia-diagnostico-136106908.html","date":"2026-11-05","written_by":"independent","quote":"Se trata de QP Prostate, un 'asistente inteligente' que, por el momento, está implantado en 12 hospitales públicos y ocho centros privados españoles","quote_translation":"It is QP Prostate, an 'intelligent assistant' that is currently deployed in 12 public hospitals and eight private centers in Spain.","supports_benefit":false}]}}},"sources[].upstream_sources":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"strategic_assessments[]":{"state":"unresolved","family":"strategic assessments"},"summary":{"state":"value_present","value":{"kind":"record_fields","fields":{"summary":"Diario de Mallorca reports that QP Prostate marked a tiny lesion on a 58-year-old man's MRI at Clínica Girona. A biopsy confirmed cancer, and after surgery he says he is free of disease.","account":"Quibim, a company in Valencia, makes QP Prostate, an AI assistant that marks likely prostate cancer lesions on MRI. Diario de Mallorca reported on 5 November 2026 that the tool is in use at 12 public hospitals and eight private centers in Spain. At Clínica Girona, it marked a tiny lesion in red on a 58-year-old man's prostate MRI. The radiologist advised a biopsy, which confirmed cancer. The man was operated on nine months before the report. He says that he is now free of disease and credits the AI with finding the tumor when it was tiny. The account is the patient's and the clinic's, and no source says whether radiologists would have found the lesion without the tool."}}},"systems[].autonomy_permissions":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"systems[].component_role":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"systems[].deployment_configuration":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"systems[].inputs_outputs":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"systems[].model_name":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"systems[].model_version":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"systems[].product_name":{"state":"value_present","value":{"kind":"record_fields","fields":{"system":"QP Prostate"}}},"systems[].provider":{"state":"unresolved","reason":"This is an explicit unresolved assignment: the sources on record do not settle this question."},"title":{"state":"value_present","value":{"kind":"record_fields","fields":{"title":"Diario de Mallorca reports that QP Prostate marked a tiny lesion on a 58-year-old man's MRI at Clínica Girona, a biopsy confirmed cancer, and after surgery he says he is free of disease","headline":"*QP Prostate* flags a tiny tumor that a biopsy confirms in Girona"}}},"version":{"state":"value_present","value":{"kind":"identifiers","identifiers":["f8135805832becbaec642a51903885630b174cb179d47492372d2c1e9c5f7c18"],"role":"SHA-256 of the complete public record and its assessments"},"evidence_note":"SHA-256 of the public record, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary."},"workflow":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"Quibim, a company in Valencia, makes QP Prostate, an AI assistant that marks likely prostate cancer lesions on MRI. Diario de Mallorca reported on 5 November 2026 that the tool is in use at 12 public hospitals and eight private centers in Spain. At Clínica Girona, it marked a tiny lesion in red on a 58-year-old man's prostate MRI. The radiologist advised a biopsy, which confirmed cancer. The man was operated on nine months before the report. He says that he is now free of disease and credits the AI with finding the tumor when it was tiny. The account is the patient's and the clinic's, and no source says whether radiologists would have found the lesion without the tool.","replication":{"produced_by":["An AI assistant that marks and grades likely lesions on prostate MRI","A radiologist who reviews the marks and advises a biopsy"],"must_hold":["A radiologist must review each mark","A biopsy must confirm the finding before treatment"],"echoes":[]}}}}}}}